S S Chiang1, S Roche2, C Contreras3, H Del Castillo4, P Canales4, J Jimenez3, K Tintaya3, M C Becerra5, L Lecca3. 1. Department of Pediatrics, Alpert Medical School, Brown University, Providence, Rhode Island, USA; Center for International Health Research, Rhode Island Hospital, Providence, Rhode Island, USA. 2. Department of Health Care Quality, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 3. Socios En Salud (Partners In Health), Lima, Peru. 4. Instituto Nacional de Salud del Niño, Lima, Peru. 5. Socios En Salud (Partners In Health), Lima, Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Abstract
SETTING: In 2012, Peru's National TB Program (NTP) reported approximately 2400 incident cases of tuberculosis (TB) disease in children aged <15 years. Peru's TB burden is concentrated in the Lima metropolitan area, particularly in poor districts such as El Agustino and La Victoria, where this study was conducted. OBJECTIVE: To identify barriers to the treatment of childhood tuberculous infection and TB disease in Lima from the perspective of front-line providers and patients' families. DESIGN: We conducted 10 semi-structured focus groups with 53 purposefully sampled primary care providers, community health workers, and parents/guardians of pediatric TB patients. We also completed nine in-depth interviews with National TB Program administrators and pulmonologists specializing in TB. Two authors performed inductive thematic analysis and identified emerging themes. RESULTS: Four main treatment barriers emerged from the data: 1) dosing errors, 2) time- and labor-intensive preparation and administration of medications, 3) provider concern that isoniazid preventive therapy (IPT) generates isoniazid resistance, and 4) poor adherence to IPT. CONCLUSION: Our findings highlight the urgent need for child-friendly formulations, provider and parent/guardian education about IPT, and strategies to promote adherence to IPT, including support and supervision by health workers and/or regimens with fewer doses.
SETTING: In 2012, Peru's National TB Program (NTP) reported approximately 2400 incident cases of tuberculosis (TB) disease in children aged <15 years. Peru's TB burden is concentrated in the Lima metropolitan area, particularly in poor districts such as El Agustino and La Victoria, where this study was conducted. OBJECTIVE: To identify barriers to the treatment of childhood tuberculous infection and TB disease in Lima from the perspective of front-line providers and patients' families. DESIGN: We conducted 10 semi-structured focus groups with 53 purposefully sampled primary care providers, community health workers, and parents/guardians of pediatric TB patients. We also completed nine in-depth interviews with National TB Program administrators and pulmonologists specializing in TB. Two authors performed inductive thematic analysis and identified emerging themes. RESULTS: Four main treatment barriers emerged from the data: 1) dosing errors, 2) time- and labor-intensive preparation and administration of medications, 3) provider concern that isoniazid preventive therapy (IPT) generates isoniazid resistance, and 4) poor adherence to IPT. CONCLUSION: Our findings highlight the urgent need for child-friendly formulations, provider and parent/guardian education about IPT, and strategies to promote adherence to IPT, including support and supervision by health workers and/or regimens with fewer doses.
Authors: Dillon T Wademan; Graeme Hoddinott; Susan E Purchase; James A Seddon; Anneke C Hesseling; Anthony J Garcia-Prats; Ria Reis; Lindsey J Reynolds Journal: PLoS One Date: 2022-07-14 Impact factor: 3.752
Authors: Courtney M Yuen; Ana K Millones; Carmen C Contreras; Leonid Lecca; Mercedes C Becerra; Salmaan Keshavjee Journal: PLoS One Date: 2019-05-17 Impact factor: 3.240
Authors: D T Wademan; L Busakwe; T J Nicholson; M van der Zalm; M Palmer; J Workman; A Turkova; A M Crook; M J Thomason; D M Gibb; J Seeley; A Hesseling; G Hoddinott Journal: Int J Tuberc Lung Dis Date: 2019-12-01 Impact factor: 2.373
Authors: Courtney M Yuen; Ana K Millones; Jerome T Galea; Daniela Puma; Judith Jimenez; Leonid Lecca; Mercedes C Becerra; Salmaan Keshavjee Journal: BMC Public Health Date: 2021-01-11 Impact factor: 3.295
Authors: Anca Vasiliu; Sabrina Eymard-Duvernay; Boris Tchounga; Daniel Atwine; Elisabete de Carvalho; Sayouba Ouedraogo; Michael Kakinda; Patrice Tchendjou; Stavia Turyahabwe; Albert Kuate Kuate; Georges Tiendrebeogo; Peter J Dodd; Stephen M Graham; Jennifer Cohn; Martina Casenghi; Maryline Bonnet Journal: Trials Date: 2021-03-02 Impact factor: 2.279
Authors: Daria Szkwarko; Yael Hirsch-Moverman; Lienki Du Plessis; Karen Du Preez; Catherine Carr; Anna M Mandalakas Journal: PLoS One Date: 2017-08-01 Impact factor: 3.240